US Broker Ratings

Concentra Group Holdings Parent (CON): Investor Outlook Reveals 28.99% Potential Upside

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) presents an intriguing prospect. Operating within the medical care facilities industry, Concentra offers..

Scholar Rock Holding Corporation (SRRK): Biotechnology Innovator with Promising Upside and Robust Buy Ratings

Scholar Rock Holding Corporation (NASDAQ: SRRK), a pioneering entity in the healthcare sector, is making significant strides in the biotechnology industry with a focus on developing..

PTC Therapeutics (PTCT) Investor Outlook: An 18% Upside Potential Amidst Robust Pipeline

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its strategic focus on rare disorders..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with a 10.5% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning entity within the biotechnology sector, is capturing investor attention with its promising portfolio of therapies targeting rare and orphan..

Vericel Corporation (VCEL): Stock Analysis Reveals a Promising 48.89% Upside Potential

Investors in the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing opportunity, as the company presents significant potential upside in its current market position...

NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside

For investors with an eye on the healthcare sector, NewAmsterdam Pharma Company N.V. (NAMS) offers a captivating opportunity. This Netherlands-based biotechnology firm, with a market capitalization..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Assessing Growth Potential with an 18% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotechnology sector, has been attracting attention with its innovative approach to treating inflammatory diseases. As a clinical-stage..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 44% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector with a notable focus on behavioral healthcare services across the U.S. and Puerto Rico...

ICU Medical, Inc. (ICUI) Investor Outlook: Analysts Signal a 19.4% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI) is at the forefront of the healthcare sector, specializing in the production and distribution of innovative medical devices used in infusion..

Warby Parker Inc. (WRBY) Stock Analysis: A Visionary Growth Story with 15.20% Revenue Surge

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, continues to capture investor attention with its innovative approach..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Examining the 19% Potential Upside in Biotech Giant

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is making significant strides in the healthcare sector, particularly within the biotechnology industry. With a focus on developing and commercializing treatments..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Gem with 22% Upside Potential

For investors eyeing the healthcare sector, Protagonist Therapeutics, Inc. (PTGX) presents an intriguing opportunity within the biotechnology industry. With a market capitalization of $5.19 billion, the..

Sotera Health Company (SHC) Stock Analysis: A Promising 11.68% Potential Upside for Investors

Sotera Health Company (NASDAQ: SHC), a key player in the healthcare diagnostics and research industry, has captured significant attention from investors due to its robust market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a 5.24% Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializes in dental and medical instruments. Despite facing a challenging financial landscape, the company..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Navigating the 64% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a Swiss-based biotechnology firm, is at the forefront of gene editing technology with its innovative CRISPR/Cas9 platform. The company’s focus on..

Merus N.V. (MRUS) Stock Analysis: Weighing the 7.78% Potential Upside for Investors

Investors with an interest in the biotechnology sector may find Merus N.V. (MRUS) an intriguing consideration, as the company offers a mix of opportunity and challenges,..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 158% Upside Potential

Investors eyeing the biotechnology sector may find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) an intriguing prospect due to its focus on rare and ultra-rare genetic diseases. Headquartered..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a 9.95% Potential Upside Amidst Healthcare Sector Challenges

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York City, is making waves within the healthcare plans industry. With a market capitalization..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking a 48% Potential Upside

In the dynamic realm of biotechnology, ADMA Biologics Inc (NASDAQ: ADMA) has carved out a niche with its specialty plasma-derived biologics, targeting immune deficiencies and infectious..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Closer Look at Its 5.38% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, specifically focusing on the discovery and development of RNA-targeted therapeutics and gene..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds